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Abstract 
Single phase cobalt ferrite (CoFe2O4, CFO) nanoparticles of a controlled size (~ 6 nm) 
exhibiting superparamagnetic properties have been synthesized by hydrothermal technique 
using oleic acid (OA) as surfactant. The oleic acid coated CFO nanoparticles are stable in non-
polar organic media, such as hexane but are not well dispersible in water. The surface of these 
snanoparticles has been further modified by citric acid using ligand exchange process, which 
makes CFO nanoparticles more stable colloidal solution in water. Citric acid coated CFO 
nanoparticles exhibits high dispersibility in water, high zeta potential, very low coercivity and 
moderate saturation magnetization. Biocompatibility of these CFO nanoparticles is 
demonstrated through cytotoxicity test in L929 cell line. 
KEYWORDS: CoFe2O4, Biomedical applications, Ligand exchange, Superparamagnetism, 
Nanoparticles. 
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1. Introduction 
In recent years magnetic nanoparticles have been extensively explored for their potentiality 
in many biomedical applications such as for targeted drug delivery [1], as contrast enhancement 
agents in magnetic resonance imaging (MRI) [2], and in hyperthermia treatments as heat 
mediators [3].The main advantage of magnetic nanoparticles for biomedical applications is its 
larger surface area for easy ligand attachment, better tissue diffusion and reduced dipole-dipole 
interaction. The magnetic properties of the nanoparticles can be tuned by controlling its size 
[4], composition [5], shape [6] and strain/defects [7]. By carefully reducing its size below to a 
critical diameter, the magnetic nanoparticles can be turned to superparamagnetic nanoparticles. 
Iron oxide magnetic nanoparticles such as Fe3O4 [2] and γ − Fe2O3 [8] have been widely 
explored for biomedical applications. The saturation magnetization and hysteresis losses of 
these iron oxide nanoparticles are small compared to pure metals (Co, Fe, or CoFe etc.), but 
the metallic nanoparticles are highly toxic and very sensitive to oxidation and hence are not 
useful for biomedical applications. Another alternative can be spinel ferrites such as MFe2O4 
(M  Co, Mn, Ni) [9, 10, 11]. Among these ferrites, CoFe2O4 is interesting due to its large curie 
temperature, high effective anisotropy and moderate saturation magnetization [12]. CFO has 
an inverse spinel structure with general formula AB2O4 (A = Fe and B = Co, Fe) where half of 
the Fe3+ occupies the octahedral sites and the other half Fe3+ occupies the tetrahedral sites 
whereas all the Co2+ occupy the octahedral sites.  
  For biomedical applications the magnetic nanoparticles should be of small sizes with 
narrow size distribution. These nanoparticles should be coated with some organic or inorganic 
material which ensure their biocompatibility, nontoxicity and colloidal stability in biophase. 
Several techniques such as microemulsion [13], coprecipitation [14], ball milling [15], sol−gel 
[16], thermal decomposition [17], sonochemical [18] and electrosynthesis [9] method have 
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been employed for the synthesis of magnetic nanoparticles but all these synthesis methods often 
produce larger size nanoparticles with wide particle size distribution. 
In the present work, we have synthesized uniform size (~6nm) CoFe2O4 magnetic 
nanoparticles using hydrothermal techniques with oleic acid as surfactant. These oleic acid 
coated CFO nanoparticles are not dispersible in water and in order to make these nanoparticles 
water dispersible, the surface of these oleic acid coated nanoparticles was modified with citric 
acid using ligand exchange method. It is found that these citric acid coated CoFe2O4 
nanoparticles makes a good colloidal solution in water in a wide range of pH. The 
biocompatibility of citric acid coated CFO nanoparticles was studied with mouse fibroblast 
L929 cells lines, using a MTT cytotoxicity assay.  
2. Experimental 
CFO nanoparticles were synthesized by hydrothermal method [7], using ferric and 
cobalt nitrate as precursors and oleic acid as surfactant. A solution of 2 mmol of ferric nitrate 
and 1 mmol of cobalt nitrate in 20 ml water was added with a 10 mmol NaOH solution, ethanol 
and 12 ml oleic acid. The resultant solution was mixed thoroughly using a magnetic stirrer and 
was put into a Teflon lined stainless steel autoclave. The autoclave was placed into a preheated 
oven at 180o C for 16 hours. After cooling, the particles were washed several times in hexane 
and ethanol. A permanent magnet was used for the separation of the nanoparticles from the 
liquid. These nanoparticles is named as OA-CFO. 
For synthesizing citric acid coated CFO nanoparticles from the oleic acid coated CFO 
nanoparticles, ligand exchange method was used. The OA-CFO nanoparticles were kept in a 
solution of toluene, citric acid and dimethyl sulfoxide (DMSO) and stirred thoroughly for 30 
hours. Modified nanoparticles were collected, washed in ethanol and dried at 60 oC. These 
citric acid coated nanoparticles is named as CA-CFO in the subsequent discussion.  
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Structural properties of CFO samples were investigated using Rigaku Ultima IV X-ray 
diffractometer (XRD) equipped with Cu Kα (λ =1.542 Å) radiation source and the morphology 
of the samples were characterized by using a JEOL JEM-2200-FS Transmission electron 
microscope (TEM). Magnetic measurements of the CFO nanoparticles were performed at room 
temperature using Quantum Design Evercool-II Physical property measurement system, in the 
magnetic field range of -4 to 4 Tesla. For the magnetic measurements samples were prepared 
by adding a known amount of CFO nanoparticles in DI water and then drop casted onto a glass 
substrate of dimensions 0.4cm × 0.4 cm.  FTIR studies of OA-CFO and CA-CFO nanoparticles 
were carried out using Thermo Scientific™ Nicolet™ iS™ 50 FT-IR Spectrometer. Zeta 
potential (𝜁) and hydro dynamic diameter of CA-CFO nanoparticles were studied using 
malvern zetasizer nano zs90. 
In vitro cell viability studies of CA-CFO nanoparticles were carried out with mouse 
fibroblast L929 cells lines, using a 3-(4 5-dimethylthiazol-2-yl)-2 5-diphenyltetrazolium 
bromide (MTT) cytotoxicity assay. The MTT cytotoxicity assay is a colorimetric assay which 
measures the cellular metabolic activity based on mitochondrial NADPH dependent 
dehydrogenase enzymes [19]. These enzymes reduce the MTT dye to form formazan crystals 
in viable cells. DMSO dissolves these crystals to give a purple colored solution, which can then 
be quantified spectrophotometrically at 540 nm, using microplate spectrophotometer 
(PowerWave XS2, BioTek Instruments, USA). 
3. Results and discussion 
XRD patterns of OA-CFO and CA-CFO nanoparticles are shown in Fig. 1. The observed 
peaks at 2θ = 30.12º, 35.44º, 43.08º, 53.52º, 57.04º and 62.58º corresponds to (220), (311), 
(400), (422), (511) and (440) planes of CoFe2O4 (JCPDS No. 22-1086). This confirms the 
formation of single phase cubic spinel structure of CoFe2O4 nanoparticles. The XRD patterns 
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of OA-CFO and CA-CFO nanoparticles are similar because these nanoparticles have same 
crystalline core of CoFe2O4. 
Scherer formula is used to determine the average crystallite size for CFO nanoparticles, 
which is given as [20]; 
t =  
0.9λ
β cosθ
      (1) 
where β represents the full width at half maximum of the XRD peak, θ is the Bragg’s 
angle, λ (1.542 Å) is the wavelength of X-ray, and  t is the average crystallite size.The average 
crystallite sizes for OA-CFO and CA-CFO nanoparticles are found as    ̴ 5.9 nm and 5.4 nm 
respectively.  
TEM images of OA-CFO nanoparticles and CA-CFO nanoparticles are shown in Fig. 
2. The histogram of the particle size distribution are also shown as inset in Fig. 2a and 2b. The 
size distribution of the CFO nanoparticles reveals that the maximum number of the particles 
has a diameter in the size range of 4 nm to 7 nm with a log normal peak appearing at 5.8 and 
5.6 nm for OA-CFO and CA-CFO nanoparticles. These results are in good agreement with the 
crystallite size obtained from XRD analysis. 
Fig. 3 shows the field dependence of magnetization for OA-CFO and CA-CFO 
nanoparticles at room temperature. OA-CFO nanoparticles are found to have a slightly high 
saturation magnetization as compared to CA-CFO nanoparticle. For OA-CFO nanoparticles 
the value of the saturation magnetization (Ms) and coercivity (Hc) are found as ~47 emu/gm 
and ~11 Oe respectively, and for CA-CFO nanoparticles, the values of the Ms and Hc are found 
as ~42 emu/gm and ~13 Oe respectively. The small values of coercivity of CFO nanoparticles 
indicates that these nanoparticles are near the superparamagnetic limit which is the ideal regime 
for several biomedical applications. 
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The lower value of saturation magnetization (Ms) of these CFO nanoparticles compared 
to the Ms value of bulk cobalt ferrite (~ 90 emu/gm) can be attributed to a “nanoscale size 
effect” according to which the magnetic moments present near the surface of the nanoparticles 
behaves differently from that present in the core of the particles and a much higher spin disorder 
is present on the surface of the particles which leads to the reduction of Ms of CFO 
nanoparticles [21].   
FTIR spectrum of OA-CFO and CA-CFO nanoparticles are shown in Fig. 4. The 
difference in FTIR spectra of OA-CFO and CA-CFO nanoparticles is due to the presence of 
different coating on CFO for both of these two samples. The presence of oleic acid on as 
synthesized OA-CFO nanoparticles was confirmed by two CH3 stretching at 2920 cm
-1 and 
2850 cm-1 present in FTIR spectra of the sample. The two bands appears near 1538 and 1410 
cm-1, which are characteristic bands of the asymmetric and the symmetric stretch of (COO). It 
is evident that oleic acid was chemisorbed onto the surface of CFO nanoparticles via its 
carboxylate group [22].  
The CA-CFO nanoparticles shows three strong absorption peaks at 3275, 1575, and 
1405 cm-1 corresponding to the stretching band of hydroxyl group (-OH), antisymmetric 𝜐as 
(COO) and symmetric 𝜐s (COO) stretching band of the carboxyl group, respectively [23]. This 
confirms that the surface of the CA-CFO nanoparticles was covered with carboxylate species 
of citric acid. An intense peak at ∼590 cm−1 is observed, which is attributed to the stretching 
of the metal ion at the tetrahedral A-site, MA↔O [24].  
The CA-CFO nanoparticles are well dispersible in water in a wide range of pH. The 
hydrodynamic diameter (DH) determined by Dynamic Light Scattering (DLS) and zeta 
potential (ζ) values for CA-CFO nanoparticles at different pH values ranging from 2.2 to 10.8, 
are shown in Fig. 5. As the ζ is related to the surface charge present on the nanoparticles, the 
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large/small value of |𝜁| indicates the more/less electrostatic repulsion between the 
nanoparticles. In the case of magnetic nanoparticles this electrostatic repulsion opposes the 
magnetic attraction acting between the nanoparticles. Initially increasing the pH from 2.2 the 
|ζ| approaches toward “0” and at pH value ~3.5, |ζ| is minimum. At this point the magnetic 
attraction exceeds the electrostatic repulsion which leads to more agglomeration of CA-CFO 
nanoparticles. Due to this agglomeration the DH shows its maximum value at pH ~3.5. At 
higher pH values (> 3.5) the |ζ| starts increasing, which increases the electrostatic repulsion 
between the nanoparticles that leads to a decrease in DH. At pH ~7, ζ is sufficiently negative (-
22.3 mV), which indicates that negative charges are present on the surface of CA-CFO 
nanoparticles in a larger amount. Smaller value of DH for CA-CFO nanoparticles indicates that 
good electrostatic repulsive forces are acting between the particles that opposes the 
agglomeration of these nanoparticles and increases the dispersion and colloidal stability in 
water. All these observations suggests that the surface modification of OA-CFO nanoparticles 
by citric acid allows us to obtain a good dispersion in water with more colloidal stability. 
The OA-CFO nanoparticles are not dispersible in water so these nanoparticle cannot be 
used in biomedical applications but the high colloidal stability of CA-CFO nanoparticles at 
neutral pH values make the CA-CFO magnetic nanoparticles a suitable candidate for 
biomedical applications. The biocompatibility of citric acid coated CFO nanoparticles was 
studied on the L929 (mouse fibroblast) cells line, using an MTT cytotoxicity assay. Cells were 
seeded at a density of 10 × 103 cells per well in 96 well plate.  The plate was incubated at 37 
°C for 24 h in a CO2 incubator. CA-CFO nanoparticles suspension was added to each well so 
that final concentration range was from 100 µg/ml to 1000 µg/ml and incubated for another 24 
h. The media was replaced with fresh media and 10 μL of 5% MTT solution, filtered through 
sterile 0.22 µm filter was added to each well and incubated for 4 h. Cell viability was calculated 
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relative to negative control (phosphate buffered saline) and a positive control (1% Triton X-
100) using the following relation: 
   Cell Viability (%) = 
Sample540nm−Positive Control540nm
Negative Control540nm−Positive Control540nm
 × 100 
Fig. 6 shows the surviving fraction of L929 cells incubated during 24 hours with 
different concentrations of CA-CFO nanoparticles and evaluated by the MTT assay. The 
synthesized CA-CFO nanoparticles were found to biocompatible at relatively high 
concentrations (100 µg/ml to 1000 µg/ml), with cell viability almost 100%, i.e. the survival 
fraction of treated cells is similar to the controls cell under the experimental conditions. This 
high cell viability of CA-CFO nanoparticles is attributed to the coating of citric acid on these 
nanoparticles through ligand exchange method. As the zeta potential of CA-CFO nanoparticles 
was found to be large (-18.8 mV), these CA-CFO nanoparticles will have long circulatory 
effect in biophase. 
4. Conclusion 
We have successfully synthesized oleic acid capped, uniform size (~6 nm) CFO 
nanoparticles by hydrothermal method and demonstrated the conversion of these nanoparticles 
to a citric acid (CA) coated CFO nanoparticles using ligand exchange method. The CA-CFO 
nanoparticles exhibits very small coercivity, moderate saturation magnetization and a high 
degree of dispersibility in water. At pH ~ 7, zeta potential of CA-CFO nanoparticles was higher 
(~22 mV), which gives CA-CFO nanoparticles colloidal stability in water. Cell viability assay 
of CA-CFO nanoparticles on L929 cell line showed no cytotoxic effect even after 24 h of 
incubation period at relatively higher concentration of CA-CFO nanoparticles, which 
establishes the potentiality of the functionalized CA-CFO nanoparticles for biomedical 
applications. 
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Figure Captions 
Fig. 1  X-ray diffraction patterns of OA-CFO and CA-CFO nanoparticles. 
Fig. 2. TEM images of (a) OA-CFO nanoparticles and (b) CA-CFO nanoparticles. The inset 
in the figure shows distribution of particle size and its log normal distribution fit. 
Fig. 3. Magnetic hysteresis loops for OA-CFO and CA-CFO nanoparticles at room 
temperature. 
Fig. 4. FTIR spectra of OA-CFO and CA-CFO nanoparticles. Arrows marked OA-CFO 
spectra corresponds to 2990 cm-1, 2850 cm-1, 1538 cm-1, 1410 cm-1 and 590 cm-1 (from 
left to right) whereas the arrows marked to CA-CFO spectra corresponds to 3275 cm-1, 
1575 cm-1, 1405 cm-1 and 590 cm-1  (from left to right). 
Fig. 5. Zeta potential and hydrodynamic diameter as a function of pH for CA-CFO 
nanoparticles. 
Fig. 6. Cytotoxicity profiles of CA-CFO nanoparticles for 24 h on L929 cell line at different 
concentrations (100, 400, 600, 800 and 1000 µg/mL) 
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Fig. 1  X-ray diffraction patterns of OA-CFO and CA-CFO nanoparticles. 
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Fig. 2. TEM images of (a) OA-CFO nanoparticles and (b) CA-CFO nanoparticles. The inset 
in the figure shows distribution of particle size and its log normal distribution fit. 
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Fig. 3. Magnetic hysteresis loops for OA-CFO and CA-CFO nanoparticles at room 
temperature. 
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Fig. 4. FTIR spectra of OA-CFO and CA-CFO nanoparticles. Arrows marked OA-CFO 
spectra corresponds to 2990 cm-1, 2850 cm-1, 1538 cm-1, 1410 cm-1 and 590 cm-1 (from left to 
right) whereas the arrows marked to CA-CFO spectra corresponds to 3275 cm-1, 1575 cm-1, 
1405 cm-1 and 590 cm-1  (from left to right). 
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Fig. 5. Zeta potential and hydrodynamic diameter as a function of pH for CA-CFO 
nanoparticles. 
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Fig. 6. Cytotoxicity profiles of CA-CFO nanoparticles for 24 h on L929 cell line at different 
concentrations (100, 400, 600, 800 and 1000 µg/mL). 
 
